본문 바로가기
KERD
논문KCI 등재

Effect of coenzyme Q10 and Ardisia japonica Blume on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux channels in simvastatin-treated guinea pigs

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Forty guinea pigs were divided into four groups and fed 0.04% cholesterol based control diet, plus 0.05% simvastatin, and statin plus 0.1%CoQ10 or 10% Ardisia Japonica Blume (AJB) leave powder for 4 weeks. Plasma total cholesterol levels decreased significantly in all groups fed the statin-containing diet compared with that in guinea pigs fed the control diet (P < 0.01). Plasma and liver triglycerides decreased significantly in the statin plus CoQ10 group compared with those in the control (both P < 0.05). Maximum platelet aggregation was significantly higher in the statin plus CoQ10 group than that in the other groups (P < 0.05). Na-K ATPase activity increased in the statin group and decreased in the statin plus CoQ10 group (P < 0.01). Na-K co-transport and Na passive transport decreased significantly in the control group compared with those in the other groups (both P < 0.05). Intracellular Na was highest in the statin group and lowest in the statin plus CoQ10 group and was correlated with Na-K ATPase activity. Thiobarbituric acid reactive substance production in platelet-rich plasma and liver tended to decrease in the statin plus CoQ10group compared with those in the other groups. Plasma glutamic-pyruvic transaminase and glutamic-oxaloacetic transaminase increased significantly in the statin group compared with those in the control (P < 0.05). These result suggest that antioxidant rich AJB did not have positive effects on cardiovascular disease parameters. The statin plus CoQ10 seemed to decrease cholesterol more efficiently than that of statin alone.

Abstract

Forty guinea pigs were divided into four groups and fed 0.04% cholesterol based control diet, plus 0.05% simvastatin, and statin plus 0.1%CoQ10 or 10% Ardisia Japonica Blume (AJB) leave powder for 4 weeks. Plasma total cholesterol levels decreased significantly in all groups fed the statin-containing diet compared with that in guinea pigs fed the control diet (P < 0.01). Plasma and liver triglycerides decreased significantly in the statin plus CoQ10 group compared with those in the control (both P < 0.05). Maximum platelet aggregation was significantly higher in the statin plus CoQ10 group than that in the other groups (P < 0.05). Na-K ATPase activity increased in the statin group and decreased in the statin plus CoQ10 group (P < 0.01). Na-K co-transport and Na passive transport decreased significantly in the control group compared with those in the other groups (both P < 0.05). Intracellular Na was highest in the statin group and lowest in the statin plus CoQ10 group and was correlated with Na-K ATPase activity. Thiobarbituric acid reactive substance production in platelet-rich plasma and liver tended to decrease in the statin plus CoQ10group compared with those in the other groups. Plasma glutamic-pyruvic transaminase and glutamic-oxaloacetic transaminase increased significantly in the statin group compared with those in the control (P < 0.05). These result suggest that antioxidant rich AJB did not have positive effects on cardiovascular disease parameters. The statin plus CoQ10 seemed to decrease cholesterol more efficiently than that of statin alone.

참고문헌 (41)

  1. King DE, "Use of statins and blood pressure", Am J Hypertens, 20, pp.937~941 (2007)
  2. Matsuno H, "Simvastatin enhances the regeneration of endothelial cells via VEGF secretion in injured arteries", J Cardiovasc Pharmacol, 43, pp.333~340 (2004)
  3. Susic D, "Beneficial pleiotropic vascular effects of rosuvastatin in two hypertensive models", J Am Coll Cardiol, 42, pp.1091~1097 (2003)
  4. Staal A, "The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity", J Bone Miner Res, 18, pp.88~96 (2003)
  5. Petanceska SS, "Statin therapy for Alzheimer's disease: will it work?", J Mol Neurosci, 19, pp.155~161 (2002)
  6. Kaneta S, "All hydrophobic HMG-CoA reductase inhibitors induce apoptotic death in rat pulmonary vein endothelial cells", Atherosclerosis, 170, pp.237~243 (2003)
  7. Littarru GP, "Coenzyme Q10 and statins: biochemical and clinical implications", Mitochondrion, 7(Suppl), pp.168~174 (2007)
  8. Nawarskas JJ, "HMG-CoA reductase inhibitors and coenzyme Q10", Cardiol Rev, 13, pp.76~79 (2005)
  9. Lamperti C, "Muscle coenzyme Q10 level in statin-related myopathy", Arch Neurol, 62, pp.1709~1712 (2005)
  10. Dhanasekaran M, "The emerging role of coenzyme Q-10 in aging, neurodegeneration, cardiovascular disease, cancer and diabetes mellitus", Curr Neurovasc Res, 2, pp.447~459 (2005)
  11. Kamzalov S, "Coenzyme Q intake elevates the mitochondrial and tissue levels of coenzyme Q and alpha-tocopherol in young mice", J Nutr, 133, pp.3175~3180 (2003)
  12. Maroz A, "Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity", Free Radic Biol Med, 46, pp.105~109 (2009)
  13. López-Lluch G, "Role of plasma membrane coenzyme Q on the regulation of apoptosis", Biofactors, 9, pp.171~177 (1999)
  14. Ryszawa N, "Effects of novel plant antioxidants on platelet superoxide production and aggregation in atherosclerosis", J Physiol Pharmacol, 57, pp.611~626 (2006)
  15. Sobotková A, "Antioxidants change platelet responses to various stimulating events", Free Radic Biol Med, 47, pp.1707~1714 (2009)
  16. Merlo Pich M, "Ubiquinol and a coenzyme Q reducing system protect platelet mitochondrial function of transfusional buffy coats from oxidative stress", Free Radic Res, 36, pp.429~436 (2002)
  17. Luzak B, "The effect of a platelet cholesterol modulation on the acetylsalicylic acid-mediated blood platelet inhibition in hypercholesterolemic patients", Eur J Pharmacol, 658, pp.91~97 (2011)
  18. Uyuklu M, "Effect of decreased plasma cholesterol by atorvastatin treatment on erythrocyte mechanical properties", Clin Hemorheol Microcirc, 36, pp.25~33 (2007)
  19. Villar J, "Erythrocyte Na(+)-Li+ countertransport in essential hypertension: correlation with membrane lipids levels", J Hypertens, 14, pp.969~973 (1996)
  20. Lijnen P, "Erythrocyte cation transport systems and membrane lipids in insulin-dependent diabetes", Am J Hypertens, 6, pp.763~770 (1993)
  21. Heilmann L, "The Na+", K+ co-transport system in erythrocytes from pregnant patients, 1993, pp.253, 167~174
  22. Duke JA, "Medicinal Plants of China, Vol", pp.705~ (1985), Reference Publications
  23. Kobayashi H, "The genus Ardisia: a novel source of health-promoting compounds and phytopharmaceuticals", J Ethnopharmacol, 96, pp.347~354 (2005)
  24. Jia Z, "Triterpenoid saponins from Ardisia crenata and their inhibitory activity on cAMP phosphodiesterase", Chem Pharm Bull (Tokyo), 42, pp.2309~2314 (1994)
  25. Newell AM, "Comparative in vitro bioactivities of tea extracts from six species of Ardisia and their effect on growth inhibition of HepG2 cells", J Ethnopharmacol, 130, pp.536~544 (2010)
  26. Folch J, "A simple method for the isolation and purification of total lipides from animal tissues", J Biol Chem, 226, pp.497~509 (1957)
  27. Kang JS, "Effect of calcium on blood pressure, platelet aggregation and erythrocyte sodium transport in Dahl salt-sensitive rats", J Hypertens, 8, pp.245~250 (1990)
  28. Scharnagl H, "Efficacy and safety of fluvastatin-extended release in hypercholesterolemic patients: morning administration is equivalent to evening administration", Cardiology, 106, pp.241~248 (2006)
  29. Saito Y, "Randomized doseresponse study of rosuvastatin in Japanese patients with hypercholesterolemia", J Atheroscler Thromb, 10, pp.329~336 (2003)
  30. Galus R, "Influence of fluvastatin on bone formation induced by demineralized bone matrix in mice", Pharmacol Rep, 58, pp.443~447 (2006)
  31. Davis HR Jr, "The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy- 3-methylglutaryl coenzyme a reductase inhibitors in dogs", Metabolism, 50, pp.1234~1241 (2001)
  32. Sawada M, "Inhibition of cholesterol synthesis causes both hypercholesterolemia and hypocholesterolemia in hamsters", Biol Pharm Bull, 25, pp.1577~1582 (2002)
  33. 김정례, "Effect of onion and beet on plasma and liver lipids, platelet aggregation, and erythrocyte Na efflux in simvastatin treated hypercholesterolmic rats", Nutrition Research and Practice, 2(4), pp.211~217 (2008), 한국영양학회
  34. 강정숙, "Effect of Coenzyme Q10 and green tea on plasma and liver lipids, platelet aggregation, TBARS production and erythrocyte Na leak in simvastatin treated hypercholesterolmic rats", Nutrition Research and Practice, 1(4), pp.298~304 (2007), 한국영양학회
  35. Dietschy JM, "Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans", J Lipid Res, 34, pp.1637~1659 (1993)
  36. Fernandez ML, "Guinea pigs as models for cholesterol and lipoprotein metabolism", J Nutr, 131, pp.10~20 (2001)
  37. Haramaki N, "Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase", Arterioscler Thromb Vasc Biol, 27, pp.1471~1477 (2007)
  38. Chello M, "Simvastatin reduces platelet-endocardium adhesion in atrial fibrillation", Atherosclerosis, 197, pp.588~595 (2008)
  39. Broncel M, "Effect of fluvastatin extended release on the protein-lipid structure of erythrocyte membrane and C-reactive protein in patients with hyperlipidemia", Pol Merkur Lekarski, 22, pp.107~111 (2007)
  40. Upaganlawar A, "Modification of biochemical parameters of gentamicin nephrotoxicity by coenzyme Q10 and green tea in rats", Indian J Exp Biol, 44, pp.416~418 (2006)
  41. Fernandez ML, "Prickly pear(Opuntica sp.) pectin reverses low density lipoprotein receptorsuppression induced by a hypercholesterolemic diet in guineapigs", J Nutr, 122, pp.2330~2340 (1992)

관련 논문AI추천

이 간행물의 다른 논문 (11건)